5-(4-fluorophenyl)-1-(tetrahydropyran-2-yl)-1H-pyrazole | 1028092-46-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-(4-fluorophenyl)-1-(tetrahydropyran-2-yl)-1H-pyrazole
• 英文别名: 5-(4-Fluorophenyl)-1-(oxan-2-yl)pyrazole；5-(4-fluorophenyl)-1-(oxan-2-yl)pyrazole
• CAS: 1028092-46-7
• 化学式: C₁₄H₁₅FN₂O
• 分子量: 246.284
• InChiKey: NISTXBNHNZRBSL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  27
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-(4-fluorophenyl)-1-(tetrahydropyran-2-yl)-1H-pyrazole 在 盐酸 作用下， 以 甲醇 、 乙酸乙酯 为溶剂， 反应 5.0h， 生成 3-(4-氟苯基)-1H-吡唑
  参考文献：
  名称：

  Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide as a novel class of dual orexin receptor antagonist

  摘要：

  Orexins play an important role in sleep/wake regulation, and orexin receptor antagonists are a focus of novel therapy for the treatment of insomnia. We identified 27e (TASP0428980) as a potent dual orexin receptor antagonist through the systematic modification of our original designed lead A. We demonstrated the potent sleep-promoting effects of 27e at ip dose of 3 mg/kg in a rat polysomnogram study. 27e exhibited relatively short half-life profiles in rats and dogs. Furthermore, accumulating evidence regarding ADME profiles indicates that the predicted human half-life of 27e should be 1.2-1.4 h. These data indicated that 27e has a short-acting hypnotic property, suggesting that 27e might be useful for treating primary insomnia while exhibiting a low risk of next-day residual somnolence. Thus, 27e and its related compounds should be further evaluated to enable advancement to clinical trials. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.01.044
• 作为产物：
  描述：

  1-(2-四氢吡喃基)-1H-吡唑-5-硼酸频哪酯 、 对溴氟苯 在 四(三苯基膦)钯 、 sodium carbonate 作用下， 以 乙醇 、 水 、 甲苯 为溶剂， 反应 2.0h， 生成 5-(4-fluorophenyl)-1-(tetrahydropyran-2-yl)-1H-pyrazole
  参考文献：
  名称：

  Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide as a novel class of dual orexin receptor antagonist

  摘要：

  Orexins play an important role in sleep/wake regulation, and orexin receptor antagonists are a focus of novel therapy for the treatment of insomnia. We identified 27e (TASP0428980) as a potent dual orexin receptor antagonist through the systematic modification of our original designed lead A. We demonstrated the potent sleep-promoting effects of 27e at ip dose of 3 mg/kg in a rat polysomnogram study. 27e exhibited relatively short half-life profiles in rats and dogs. Furthermore, accumulating evidence regarding ADME profiles indicates that the predicted human half-life of 27e should be 1.2-1.4 h. These data indicated that 27e has a short-acting hypnotic property, suggesting that 27e might be useful for treating primary insomnia while exhibiting a low risk of next-day residual somnolence. Thus, 27e and its related compounds should be further evaluated to enable advancement to clinical trials. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.01.044

文献信息

• A Simple, Modular Method for the Synthesis of 3,4,5-Trisubstituted Pyrazoles
  作者：Mark McLaughlin、Karen Marcantonio、Cheng-yi Chen、Ian W. Davies

  DOI：10.1021/jo800321p

  日期：2008.6.1

  approach for the regiocontrolled preparation of pyrazoles bearing substituents on all three carbon atoms is described. Central to this method is the use of a switchable metal-directing group (MDG) to enable sequential direct lithiation of the 3- and 5-positions of the pyrazole ring. Pyrazole boronic esters obtained from these lithiated intermediates can undergo efficient Suzuki cross-coupling under

  描述了用于在区域上可控制地制备在所有三个碳原子上均带有取代基的吡唑的模块化方法。该方法的核心是使用可转换的金属导向基团（MDG），以实现吡唑环的3位和5位的顺序直接锂化。从这些锂化中间体获得的吡唑硼酸酯可以在开发的非水条件下进行有效的Suzuki交叉偶联，从而将不良的蛋白水解性脱硼降至最低。4-位的卤代提供了在剩余的碳原子上进行取代的手段。